GENÉTICA MOLECULAR EN ONCOHEMATOLOGÍA
Hospital Universitario Príncipe de Asturias
Alcalá de Henares, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario Príncipe de Asturias (6)
2024
-
Impact of somatic gene mutations on the risk of thrombosis in myelofibrosis
Leukemia
-
Integrating AIPSS-MF and molecular predictors: A comparative analysis of prognostic models for myelofibrosis
HemaSphere
-
The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis
American Journal of Hematology
2016
-
Current opinion and consensus statement regarding the diagnosis, prognosis, and treatment of patients with essential thrombocythemia: a survey of the Spanish Group of Ph-negative Myeloproliferative Neoplasms (GEMFIN) using the Delphi method
Annals of Hematology, Vol. 95, Núm. 5, pp. 719-732
-
Minimal residual disease evaluation by flow cytometry is a complementary tool to cytogenetics for treatment decisions in acute myeloid leukaemia
Leukemia Research, Vol. 40, pp. 1-9
2012
-
Response to imatinib mesylate in patients with hypereosinophilic syndrome
International Journal of Hematology, Vol. 96, Núm. 3, pp. 320-326